GL1X · GenesisL1 explorer

Research workbench

Engineered single chain antibody C9+C14 scfv

Analyse Engineered single chain antibody C9+C14 scfv in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6P79
Type
protein
Length
227 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Engineered antibody heavy chain; Engineered antibody light chain
Pockets
3 · best druggability 0.44

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HEngineered antibody heavy chainprotein11910% helix, 53% strand—
LEngineered antibody light chainprotein1083% helix, 49% strand—

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11450.440.7627empty
2590.300.7517empty
3500.240.7217empty

Interfaces

1 interface between chains.

  • H–L · 922 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6P79 · Engineered single chain antibody C9+C14 ScFv · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.